Abnormalities in itch sensation and skin barrier function in atopic NC/Tnd mice

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 8, 2013, Pages 1248-1252

  Amagai, Yosuke ^a   Matsuda, Hiroshi ^a   Tanaka, Akane ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Atopic dermatitis; Itch; NC Tnd mouse; SCLABA Real

Indexed keywords

CALCIUM; CAPSAICIN; CATION CHANNEL; CERAMIDE; CHLOROQUINE; GASTRIN; MAGNESIUM; SEROTONIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST; VOLTAGE DEPENDENT CATION CHANNEL;

ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; BIOLOGICAL MODEL; DATA ANALYSIS SOFTWARE; NONHUMAN; PAIN; PRURITUS; SCRATCHING; SKIN ALLERGY; SKIN FUNCTION; SKIN SENSITIVITY; STRATUM CORNEUM;

EID: 84883149690     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00333     Document Type: Article

References (25)

1. Johansson SGO, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wüthrich B. Guidelines for treatment of atopic eczema (atopic dermatitis) Part I. Allergy, 56, 813-824 (2001).
2. Williams HC. What is atopic dermatitis and how should it be defined in epidemiological studies? Cambridge University Press, pp. 3-24 (2000).
3. Schmid-Ott G, Jaeger B, Meyer S, Stephan E, Kapp A, Werfel T. Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison with healthy controls. J. Allergy Clin. Immunol., 108, 455-462 (2001).
4. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet., 38, 441-446 (2006).
5. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ. Epidermal barrier dysfunction in atopic dermatitis. J. Invest. Dermatol., 129, 1892-1908 (2009).
6. O'Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J. Allergy Clin. Immunol., 122, 689-693 (2008).
7. Zollner TM, Wichelhaus TA, Hartung A, Von Mallinckrodt C, Wagner TO, Brade V, Kaufmann R. Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin. Exp. Allergy, 30, 994-1000 (2000).
8. Beltrani VS. Suggestions regarding a more appropriate understanding of atopic dermatitis. Curr. Opin. Allergy Clin. Immunol., 5, 413-418 (2005).
9. Proksch E, Fölster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J. Dermatol. Sci., 43, 159-169 (2006).
10. Boguniewicz M. Atopic dermatitis: beyond the itch that rashes. Immunol. Allergy Clin. North Am., 25, 333-351, vii (2005).
11. Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature, 448, 700-703 (2007).
12. Tominaga M, Ogawa H, Takamori K. Histological characterization of cutaneous nerve fibers containing gastrin-releasing peptide in NC/Nga mice: an atopic dermatitis model. J. Invest. Dermatol., 129, 2901-2905 (2009).
13. Namer B, Carr R, Johanek LM, Schmelz M, Handwerker HO, Ringkamp M. Separate peripheral pathways for pruritus in man. J. Neurophysiol., 100, 2062-2069 (2008).
14. Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF. Cellular basis of itch sensation. Science, 325, 1531-1534 (2009).
15. Shim WS, Tak MH, Lee MH, Kim M, Kim M, Koo JY, Lee CH, Kim M, Oh U. TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J. Neurosci., 27, 2331-2337 (2007).
16. Xiao B, Patapoutian A. Scratching the surface: a role of pain-sensing TRPA1 in itch. Nat. Neurosci., 14, 540-542 (2011).
17. Imamachi N, Park GH, Lee H, Anderson DJ, Simon MI, Basbaum AI, Han SK. TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc. Natl. Acad. Sci. U.S.A., 106, 11330-11335 (2009).
18. Wilson SR, Gerhold KA, Bifolck-Fisher A, Liu Q, Patel KN, Dong X, Bautista DM. TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch. Nat. Neurosci., 14, 595-602 (2011).
19. Yun JW, Seo JA, Jang WH, Koh HJ, Bae IH, Park YH, Lim KM. Antipruritic effects of TRPV1 antagonist in murine atopic dermatitis and itching models. J. Invest. Dermatol., 131, 1576-1579 (2011).
20. Lim KM, Park YH. Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin diseases. Arch. Pharm. Res., 35, 393-396 (2012).
21. Sekine R, Satoh T, Takaoka A, Saeki K, Yokozeki H. Anti pruritic effects of topical crotamiton, capsaicin, and a corticosteroid on pruritogen-induced scratching behavior. Exp. Dermatol., 21, 201-204 (2012).
22. Aioi A, Tonogaito H, Suto H, Hamada K, Ra CR, Ogawa H, Maibach H, Matsuda H. Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis. Br. J. Dermatol., 144, 12-18 (2001).
23. Tanaka A, Jung K, Matsuda A, Jang H, Kajiwara N, Amagai Y, Oida K, Ahn G, Ohmori K, Kang KG, Matsuda H. Daily intake of Jeju groundwater improves the skin condition of the model mouse for human atopic dermatitis. J. Dermatol., 40, 193-200 (2013).
24. Ishii I, Kurozumi K, Orito K, Matsuda H. Automatic scratching pattern detection for laboratory mice using high-speed video images. IEEE Trans. Autom. Sci. Eng., 5, 176-182 (2008).
25. Nie Y, Ishii I, Yamamoto K, Orito K, Matsuda H. Real-time scratching behavior quantification system for laboratory mice using high-speed vision. J. Real-Time Image Proc., 2007, 628-633.